In DLBCL samples, 4 of 34 (12%) samples were positive for EBNA and LMP-1 by immunohistochemistry and for EBER at ISH, whereas the remainder were negative for all three markers. Here, PDLIM7 is linked to diffuse large B-cell lymphoma.